UC Davis Physicists' Mathematical Model Suggests Treatment for Mad Cow Disease

UC Davis Physicists' Mathematical Model Suggests Treatment for Mad Cow Disease

August 17, 2001 AScribe Newswire

DAVIS, Calif., Aug. 17 -- Diseases such as mad cow disease [bovine spongiform encephalopathy or BSE], which are caused by faulty proteins called prions, could be treated by adding closely related, noninfectious prions from other species. This sort of therapy could increase the incubation period of the disease well past a human lifetime, according to a theoretical study by physicists at the University of California, Davis.

Prion diseases like BSE are caused when a common protein in the brain, PrP, does not fold properly. Somehow, this faulty protein makes other PrP proteins fold in the same way. The misfolded proteins build up and stick together, forming mats and tangles in the brain. Graduate student Alex Slepoy and colleagues built a mathematical model of prion growth. They set rules for how a few infectious prions convert normal PrP proteins around them. As more proteins are altered and can affect their neighbors, the damage spreads at an increasing rate.

The change in protein folding takes less than a billionth of a second, but the disease that results can take decades to develop, said Daniel Cox, who with fellow UC Davis physicist Rajiv Singh is one of the senior authors on the study. The model was intended to bridge the gap between these time scales, Cox said. Predictions from the model were a good fit with data from the BSE epidemic in cattle in England, he said.

Prions can jump from one species to another. Some cases of human disease in England were likely caused by meat contaminated with BSE prions. But in some cases, the prions are incompatible. For example, mouse prions can attack hamsters, but hamster prions do not thrive in mice.

The UC Davis team used their model to see what would happen if incompatible, foreign prions in their correctly folded form were added to a prion infection in progress. They found that if the dose were high enough, the foreign prions would block infectious prions from converting normal proteins and forming aggregates. This would slow down or stop the spread of the disease.

Although this treatment is only a theoretical possibility at the moment, this sort of therapy could increase the disease incubation time well past a human lifetime. Cox and Singh are now hoping to use a similar model to study Alzheimer's disease, based on data collected by the UC Davis Medical Center.

The study is published in a recent issue of Physical Review Letters.

Daniel Cox, 530-752-1789; cox@physics.ucdavis.edu
Rajiv Singh, 530-752-4710; singh@physics.ucdavis.edu
Andy Fell, UC Davis News Service, 530-752-4533;

Home | News | Organics | GE Food | Health | Environment | Food Safety | Fair Trade | Peace | Farm Issues | Politics
Español | Campaigns | Buying Guide | Press | Search | Donate | About Us | Contact Us

Organic Consumers Association - 6771 South Silver Hill Drive, Finland MN 55603
E-mail: Staff · Activist or Media Inquiries: 218-226-4164 · Fax: 218-353-7652
Please support our work. Send a tax-deductible donation to the OCA

Fair Use Notice: The material on this site is provided for educational and informational purposes. It may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. It is being made available in an effort to advance the understanding of scientific, environmental, economic, social justice and human rights issues etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have an interest in using the included information for research and educational purposes. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner. The information on this site does not constitute legal or technical advice.